Accelerating global chemical product innovation and development

Scientific and regulatory support to market and sustain your products in any jurisdiction.

Competitive Advantage

Acta is a global scientific and regulatory consulting firm that assists companies that make and use chemicals with strategic commercialization planning and complex product registration and compliance matters.

We partner with our clients to help them get products quickly and efficiently to market — in any country or locale — and keep them there when challenged by a new regulatory regime, issue, or set of rules.

More About Us

Knowledge & Insights

  September 12, 2025
Memoranda
PFAS – What to Know Now, and What to Expect

Perfluoroalkyl and polyfluoroalkyl substances (PFAS) are attracting global legal, regulatory, commercial, and litigation attention as no other...

  October 24, 2025
Memoranda
AICIS Will Require Information on 522 PFAS Imported or Manufactured in Australia

On October 14, 2025, the Australia Industrial Chemicals Introduction Scheme (AICIS) announced that it has initiated an evaluation on the introduction...

  October 15, 2025
Memoranda
New Mexico Publishes Proposed Rule to Implement PFAS Protection Act, Will Hold Webinar on October 22, 2025

Following up on the New Mexico Environment Department’s (NMED) September 25, 2025, webinar on a labeling requirement for products containing...

  October 14, 2025
Global Regulatory Updates
Global Regulatory Developments for October 2025

Register Now For “Phthalate Risk Evaluation under TSCA and the Potential Impacts to the Plastics Industry,” October 30, 2025, 11:00...

  September 24, 2025
Memoranda
EPA Proposes to Amend TSCA Risk Evaluation Framework

On September 23, 2025, the U.S. Environmental Protection Agency (EPA) proposed highly anticipated amendments to the procedural framework rule for...

  August 29, 2025
Memoranda
ECHA Publishes Updated REACH Restriction Proposal for PFAS

The European Chemicals Agency (ECHA) announced on August 20, 2025, that it published an updated proposal to restrict per- and polyfluoroalkyl...

Seminars & Webinars

  October 22, 2025
Seminars & Webinars
PFAS in Consumer Products: Navigating Multi-State Compliance and Regulatory Strategy, December 2, 2025, 11:00 a.m. – 12:00 p.m. (EST), via webinar

Acta and B&C are pleased to present “PFAS in Consumer Products: Navigating Multi-State Compliance and Regulatory Strategy,” a Lexology...

  November 3, 2025
Seminars & Webinars
HCPA 2025 Annual Meeting, December 7-10, 2025, Fort Lauderdale, FL

HCPA’s Annual Meeting engages on the public policy issues that impact the household and commercial products industry. Thought leaders will discuss...

  October 29, 2025
Seminars & Webinars
TSCA Developments 2026, February 5, 2026, via webinar

Chemical Watch presents TSCA Developments 2026, covering TSCA and its business-critical implications, including risk evaluation and management rules,...

With offices in the U.S., UK, and Europe, and partners and agents in China, South Korea, Turkey, Mexico, and more, Acta offers expertise with regulatory programs and chemical product approvals in North America, Europe, South and Central America, and Asia.

Our Firms

our people

Experienced industry and agency scientists, including organic chemists, toxicologists, exposure experts, and five Ph.D.’s. Government affairs and regulatory specialists including four high-level EPA alumni. Business strategists with decades of experience directing worldwide regulatory compliance.

Acta consultants manage products from concept to approval, delivering skills and experience with specific product areas in government and industry.

Our three affiliated firms -- B&C, Acta, and BCCM -- provide a full range of global support for the commercialization of chemicals, biocides, and products of industrial biotechnology, nanotechnology, and synthetic biology.